Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04877769
Status:
COMPLETED
Last Update Posted:
2022-02-25
First Post:
2021-05-04
Brief Title:
Bronchopulmonary PK of AT-527 R07496998
Sponsor:
Atea Pharmaceuticals Inc
Organization:
Atea Pharmaceuticals Inc
Study Overview
Official Title:
A Phase 1 Open-label Randomized Study in Healthy Subjects to Assess the Bronchopulmonary Pharmacokinetics Safety and Tolerability of AT-527 a Potential Treatment for COVID-19
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the safety tolerability and bronchopulmonary pharmacokinetics PK of AT-527 R07496998
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None